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Abstract
Background: Tumorigenesis is thought to be the consequence of gene mutation and disordered
gene expression. However, the detailed molecular mechanism underlying the development and
progress of colon cancer have not been elucidate completely. This study aimed to find out the
genes associated with cancer biological pathways involved in transformation and tumorigenesis.
Methods: Normal intestinal cell line 6 (IEC-6) cells were transformed to cancer cells by treatment
with cancerogenic agent of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and Phorbol 12-
myristate 13 acetate (PMA). Then we investigated the altered gene expression of transformed IEC-
6 cells by the microarray containing 113 genes associated with cancer pathway. Also the altered
miRNAs of transformed IEC-6 cells were analyzed by array hybridization (miRCURY Array v9.2,
Exiqon). The levels of acetylated histone H3 in transformed IEC-6 cells was evaluated by western
blot.
Results: Cell proliferation was significantly increased as IEC-6 cells were transformed and tumor
xenografts could be detected in animals as transformed IEC-6 cells were inoculated subcutaneously
in nude mice. Result of microarray showed nine genes were increased and two decreased, as well
as 13 miRNA were increased and 97 decreased. Verification by real-time PCR implies that the data
obtained from microarray analysis were reliable. Western blot showed the levels of acetylated
histone H3 were increased dramatically after MNNG/PMA treatment.
Conclusion: Our results showed many important biological pathways and miRNAs were involved
in transformation and tumorigenesis of IEC-6 cells, which suggested the transformation of normal
cells was involved with large mount of genetic and epigenetic variation.
Background
Colon cancer is one of the most common cancers associ-
ated with considerable mortality and morbidity rates
[1,2]. Most colorectal malignancies are sporadic, but a
fraction of colon cancers occur in an inherited fashion.
Familial adenomatous polyposis (FAP) is one of the best-
characterized inherited colon cancers, with patients devel-
oping hundreds to thousands of preneoplastic colonic
polyps in early adulthood [3]. Tumor suppressor APC was
thus cloned as the causative gene for this disease. Other
genes associated with colon cancer have already outlined,
which causally interpret the development of inherited
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series of genes account for the susceptibility of colon can-
cer.
Much effort was paid to address the cancer biological
pathways such as cell apoptosis, cell cycle control and sig-
nal transduction in transformed cell models, in which car-
cinogens were applied [5]. Chemical carcinogens could be
divided into two categories (initiators and promoters)
based on the two-stage model of carcinogenesis, though
criticism about this theory was still existed [6]. So the
transformation of normal cells could be divided as two-
stages of initiation and promotion [7]. Most initiators can
be detected by various genotoxicity tests. However, the
promoters, which do not damage DNA directly, can facil-
itate tumor development from initiated cells. Now, more
and more chemicals have been identified as tumor pro-
moters in experimental animals and in cell transforma-
tion models, and their molecular mechanisms have been
undoubtedly elucidated [8]. Two of the most frequently
used chemicals are MNNG and PMA. For example, BALB/
c-3T3-cell was successfully transformed by MNNG and
PMA treatment [9]. As a consequence result, transformed
foci were the final outcome of transforming cells in a
malignant state. This kind of transformation assay can
detect both initiating and promoting activities, which
might be a screening tool for detection of not only tumor
initiators but also tumor promoters such as non-genoto-
xic carcinogens.
The process of adenoma growth and transformation was
accompanied by cumulative mutations in genetic path-
ways that confer a growth advantage of colon cancer.
These pathways included cell cycle controlling, cell signal-
ing pathway, cell apoptosis and adhesion [10]. So the
major challenge is to identify the molecular signatures
that indicate increased likelihood for colon cancer pro-
gression. Most of importantly, it has been reported that
microRNA (miRNAs) was involved in the development of
caner [11,12]. Characteristic patterns of miRNAs expres-
sion are precisely regulated. Deviations from normal pat-
tern of expression may play a role in diseases, such as in
tumorigenesis and progress. Indeed, altered miRNAs
expression has been reported in many types of cancer
cells, although the functional significance of these
changes has yet to be fully addressed [13,14]. As colon
caner concerned, aberrantly expressed or mutation of
individual miRNAs were reported [15-17]. For example,
miR-143 and miR-145 consistently display reduced
steady-state levels of the mature miRNAs at the adenoma-
tous and cancer stages of colorectal neoplasia, by compar-
ative analyzing of human samples. Furthermore, miR-143
and miR-145 would be potentially useful as diagnostic
and therapeutic tools for colon cancer and other types of
cancer [18,19]. With the accumulating evidences in the lit-
erature that new genes found to be implicated in colon
cancer, the detailed molecular mechanism underlying the
development and progress of colon cancer remains
unknown.
To find out the genes associated with cancer biological
pathways involved in transformation and tumorigenesis,
we transformed normal IEC-6 cells to cancer cells by treat-
ment with cancerogenic agent of MNNG and PMA. IEC-6
cell line was derived from normal rat intestinal epithelia
[20]. We transformed IEC-6 cells, and identified the
altered gene expression by rat Oligo GEArray microarray
of the six biological pathways involved in transformation
and tumorigenesis. At the same, we indentified the altered
miRNAs of transformed IEC-6 cells by array hybridiza-
tion. Our result gave clues to find out the molecular mech-
anism of development and progress of colon cancer.
Materials and methods
Cell culture, animal and reagents
Chemicals employed were obtained from the following
sources: MNNG and PMA from Sigma Chemical Co. (St.
Louis, MO, USA). These chemicals were dissolved in
dimethyl sulfoxide (DMSO, from Sigma Chemical Co.)
before addition to the cultures. The final concentration of
DMSO was 0.1%. Antibodies against acetylated histone
H3 and GAPDH were from SantaCruz (California, USA).
The rat Oligo-GE-Array (9.2 version) was supplied Exiqon
(Denmark).
Male Balb/c nude mice, 6–8 weeks of age, were obtained
from The Animal Facility of Third Military Medical Uni-
versity (Chongqing, China). Animals were housed under
controlled temperature, humidity and day-night cycle
with food and water. All animal experiments were con-
ducted according to the Cancer Statement for the Use of
Animals in Cancer Research, and approved by the institu-
tional committee for animal research of Third Military
Medical University, Chongqing, China.
Cell culture and cell transformation
IEC-6 cells (ATCC, USA) were cultured in DMEM (Logan,
USA) containing 10% fetal calf serum (Hyclone), penicil-
lin (100 U/mL), and streptomycin (100 μg/mL).
For cell transformation, exponentially growing cells were
seeded at a density of 105 cells per 60-mm dish in 5 ml of
culture medium. Twenty-four hours after seeding, the cells
were treated with 1 μg/ml MNNG for 8 h and then grown
in normal medium for 3 days. Then the cell culture was
grown in a medium containing PMA at concentrations of
100 ng/ml for 3–4 days of promotion stage. The MNNG/
PMA treatment was repeated 11 times and the finally
treated IEC-6 cells were tested for transformation proper-
ties. Normal IEC-6 cells were used as negative control.Page 2 of 10
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The efficiency of colony formation in semisolid medium
was measured by the procedure described by MacPherson
[21]. Cells suspended in 3.0 ml of 0.3% agar with com-
plete medium and were plated in 60-mm dishes over a
layer of 0.7% agar containing complete medium. A final
concentration was 1 × 104 cells per dish and allowed to
harden. Plates were incubated at 37°C in a 5% CO2
humidifed atmosphere for 21 days and scored for clones.
Colony formation efficiency in semisolid agar was
expressed as the percentage of total cells that formed col-
onies containing at least 50 cells.
Tumor development in nude mice
Normal or transformed IEC-6 cells were trypsinized and
collected by centrifugation. Male Balb/c nude mice were
inoculated subcutaneously with 5 × 105 IEC-6 cells in the
dorsal aspect of the neck (4 mice in each group). Human
colon cancer SW480 cells were used as positive control,
and the same amount of cells were inoculated in nude
mice as well. All the mice were further raised for 4–8
weeks, and the tumor weight was scored after the mice
were kindly sacrificed. Dissected organs were kept in
Bouin solution for 24 h, replaced with 70% ethanol for
fixation, and subsequently immersed in paraffin, and l0
μm sections were cut with a microtome and stained with
hematoxylin-eosin.
Cell growth curve
Exponentially growing normal and transformed IEC-6
cells were cultivated in 96-well plate, with 1 × 104 cells in
each well. Twelve hours later, 3H-TdR 7.4 × 104Bq/ml was
added into the culture media, and the plate was returned
to the incubator for further cultivation. Cells were washed
with cold PBS after discarding the culture media at indi-
cated time. Excess 3H-TdR was removed by washing with
3 ml PBS. The cells were resuspended in 10% trichloroace-
tic acid (TCA) with vigorous vortexing. The cellular lysates
were vacuum-filtered and then washed with cold 5% TCA.
Incorporated 3H-TdR was measured in a liquid scintilla-
tion counter (Beckman LS5000TA, Fullerton, California,
USA). The procedures were performed 3 times in dupli-
cate 24-well culture dishes. Values are expressed as mean
± SEM.
Gene expression studies using Rat Oligo GEArray
A rat Oligo GEArray microarray (Exiqon, Denmark) was
employed to detect altered gene expression associated
with cell transformation. RNA preparation: Total RNA was
isolated from the cells of each group using TriPure reagent
kit according to the manufacturer's protocol (Roche Diag-
nostics Co.). The integrity of RNA sample was assessed by
viewing the ethidium bromide-stained 28 S and 18 S
ribosomal RNA bands, and the purity of RNA sample was
verified by the absorption ratio OD260 nm/OD280 nm. Equal
amounts of RNA isolated from normal and transformed
IEC-6 cells were pooled for the following microarray
detections. 3 μg total RNA was reverse transcribed into
Biotin-16-dUTP-labeled cDNA probes with the TrueLabe-
ling-AMP method according to the manufacturer's
instructions. The microarray membranes were pre-hybrid-
ized at 60°C for at least 2 h. Hybridization of the Biotin-
labeled cDNA probes to the membranes was carried out at
60°C overnight with slow agitation in a hybridization
oven. The hybridized membranes were washed in saline
sodium citrate buffer. Then membranes were incubated
with alkaline phosphatase-conjugated streptavidin,
washed and incubated with the chemiluminescent sub-
strate CDP-Star. Images of the membranes were acquired
using the Chemidoc XRS system (Biorad Laboratories)
and analyzed. The relative expression level of each gene
was determined by comparing the signal intensity of each
gene in the array after correction for background and nor-
malization.
microRNA chips
miRCURY LNA™ microRNA chips (Exiqon, Vedbaek,
Denmark) were employed to detect altered miRNA
expression associated with cell transformation. The chips
(version 9.2) contained totally 2056 probes, including
human, mouse and rat miRNA genes, in triplicate. Total
RNA (2–4 μg) was 3'-end-labeled using T4 RNA ligase and
a Cy3-labeled RNA linker by the following procedure:
RNA in 2.0 μL of water was combined with 1.0 μL of CIP
buffer and CIP (Cat#208021, Exiqon). The mixture was
incubated for 30 min at 37°C, and was terminated by
incubation for 3 min at 80°C. Then 3.0 μL of labeling
buffer, 1.5 μL of fluorescent label, 2.0 μL of DMSO, 2.0 μL
of labeling enzyme were added into the mixture. The labe-
ling reaction was incubated for 1 h at 16°C, and termi-
nated by incubation for 15 min at 65°C. The labeled RNA
was then combined with hybridization buffer, herring
sperm DNA and DEPC-treated water. The samples were
first denatured for 1–2 min at 80°C and then hybridized
to the microarray for 16–20 h at 65°C under a lifterslip.
Post-hybridization washes were done using Wash bufer
kit (Cat#208021, Exiqon), according to the instructions of
the manufacturer.
Real-time qPCR
RNA samples were extracted from normal and trans-
formed IEC-6 cells. A total of 5 μg RNA was reverse tran-
scribed to cDNA according to the manufacturer's
directions (Roche Diagnostics, USA). Specific primers
were designed using the Primer Express software (Applied
Biosystems, USA) and were checked for gene specificity
using NCBI/Blast (Table 1). In presence of SYBR I Green
(BioFlux, Japanese) the primers were used to amplify the
expressed cDNA of individual gene using the ABI 5700
real-time PCR system (Applied Biosystems, USA). The rel-Page 3 of 10
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expression level of the GAPDH, according to the formula:
ΔΔCt = (Ctsample-Ctref)N-(Ctsample-Ctref)T, and the estimated
expression ratio is equal to 2ΔΔCt. To quantify miRNA,
total RNA was reverse transcripted using specific RT prim-
ers (Table 2), and subsequent PCR was performed as
above. The relative abundance of each miRNA was nor-
malized by the expression level of U6 RNA.
Western Blot
A cell suspension of normal and transformed IEC-6 cells
was centrifuged and the cell pellet was washed with ice-
cold PBS. Total proteins were extracted with lysis buffer
(150 mmol/L NaCl, 50 mmol/L Tris-HCl, pH 7.4, 2
mmol/L EDTA, 1% NP-40) containing protease inhibi-
tors. Total protein (30 μg per lane) was resolved on SDS-
polyacrylamide gel and transferred onto a nitrocellulose
membrane and incubated with anti-acetylated histone H3
and anti-GAPDH antibodies (Santa Cruz, California), fol-
lowed by incubation with corresponding secondary anti-
bodies. The bands were visualized by using the enhanced
chemiluminescence system (Pierce, Rockford, IL). To val-
idate the reproducibility, the tests were repeated for at
least 3 times.
Statistical analysis
Statistical analysis was performed using the independent
2-tailed t-test. All P values were two-tailed and considered
statistically significantly if less than 0.05. Means, standard
errors, and P values were calculated using SPSS version
11.0 for Windows.
Results
Cell transformation of IEC-6 cells
The method has been well established for cell transforma-
tion of normal cells with MNNG and PMA. We treated
IEC-6 cells with MNNG and PMA for 12 times. After the
final treatment, we detected the colony formation in sem-
isolidified agarose of normal and MNNG/PMA treated
IEC-6 cells. Transformed foci of normal IEC-6 cells were
0.02% and that of MNNG/PMA treated IEC-6 cells were
0.37%. MNNG/PMA treatment markedly enhanced the
production of transformed foci (Table 3; p < 0.01).
Table 1: Sequences of forward and reverse primers for real-time quantitative PCR
GeneBank no. Gene Sequence(5'-3') Product (bp)
NM_001014786 Ifna1 Fwd GTGACCTGCCTCATACTCATAACC 443
Rev GACTTCTGCTTTGACCACCTCCC
NM_022197 Fos Fwd GAGAATCCGAAGGGAAAGGAATAA 252
Rev GTCAAGTCCAGGGAGGTCACAGA
NM_012603 Myc Fwd TCCTGTACCTCGTCCGATTCCAC 495
Rev ACGCTTCAGCTCGTTTCTCCTCT
NM_031334 Cdh1 Fwd GCCATCGCCTACACCATCCTCAG 282
Rev ACGGGCACCGACCTCATTCTCAA
NM_013135 Rasa1 Fwd CTACAACACTTGCGAGTACCTTG 276
Rev GAACTGATTTCTGTAAACACCCATA
Table 2: Specifice RT primer and PCR primers
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MNNG/PMA treated IEC-6 cells. Cell proliferation was
determined by 3H-TdR, which indicated the DNA synthe-
sis. As shown in Fig. 1, cell growth of MNNG/PMA treated
IEC-6 cells was significantly increased, compared with
that of normal IEC-6 cells. The increased cell growth was
coincident with the property of cancer cells. To further
confirm its cancerous character, MNNG/PMA treated IEC-
6 cells were inoculated subcutaneously in nude mice. As
expected, tumor xenografts were detected in all animals 4
weeks later, which was coincident with the result of
human cancer cell SW480. However, no tumor xenograft
was visible in mice inoculated with normal IEC-6 cells
even 8 weeks after inoculation. Fig. 1b showed the tumors
were low- differentiated carcinomas. Histologically, the
tumor cells of xenografts were arranged in flakiness and
nest with round or polygon in shape. Tumor giant cells
and mitotic phases could be seen. This suggested MNNG/
PMA treated IEC-6 cells had been fully transformed.
Changes of gene expression detected by microarray 
analysis
To elucidate the molecular mechanisms involved in cell
transformation of IEC-6 cells, the rat Oligo GEArray
microarray was used to identify genes with altered expres-
sion level after cell tranformation, compared with its nor-
mal controls. The microarray comprised 113 genes
representative of the six biological pathways involved in
transformation and tumorigenesis. As determined by
repetitive microarray evaluations, a total of 11 genes
exhibited differential expression of more than 2.0-fold
compared with normal IEC-6 cells. Of these, nine genes
were up-regulated and 2 were down-regulated (Table 4).
The category of altered genes included apoptosis and cell
senescence (Cflar, Bax), cell cycle control and DNA dam-
age repair (Mdm2, Ccne1), angiogenesis (Ifna1, Egfr),
adhesion (Itgav, Cdh1) and signal transduction (Fos, Myc,
Rasa1).
Table 3: Transformation of IEC-6 cells by MNNG and PMA1.
Cell type dishes Number of clonies Clong efficiency in soft agar(%)
normal 4 2 ± 0.1 0.02
MNNG/PMA 4 37 ± 0.2 0.37*
*p < 0.01 compared to untreated cells.
Transformation of normal ICE-6 cellsFigure 1
Transformation of normal ICE-6 cells. (A) Cell growth curves of normal and MNNG/PMA treated IEC-6 cells. (B) Histo-
logically analysis of tumor xenografts inoculated with transformated IEC-6 cells.
A BPage 5 of 10
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PCR
To confirm and validate the results obtained from micro-
array, we analyzed the expression of selected differentially
expressed genes by real-time qPCR. Six genes were
selected from the up-regulated and downregulated genes
because of its ratio and putative gene functions. The ratios
representing gene expression changes were log2-trans-
formed in the histograms for these genes. The validation
experiments showed expression patterns of other genes
comparable to the microarray data (Fig. 2). This implies
that the data obtained from microarray analysis were reli-
able.
Changes of miRNAs expression
To determine the alteration of miRNA expression in trans-
formed IEC-6 cells, total RNA samples from normal and
transformed IEC-6 cells were isolated and hybridized to
miRNA microarrays, comprising LNA-modified probes
for all rat miRNAs in release 9.2 of the miRBase microRNA
Registry. Expression profiling showed that a large set of
miRNAs was expressed in IEC-6 cells. In agreement with
other reports, several miRNAs, including miR-320, miR-
494, miR-503, and members of the let-7 family, were
highly expressed in IEC-6 cells, giving strong hybridiza-
tion signals on the miRNA arrays. The top 5 miRNAs,
which were highly expressed in IEC-6 cells, were miR-320,
miR-494, miR-503, miR-185 and miR-206. Among them,
the expression of miR-185 was altered in transformed
IEC-6 cells. Totally, 20 miRNAs showed evidence of being
differentially expressed within the transformed IEC-6 sug-
gesting that they might be associated with the process of
cell tranformation. For example, miR-208, miR-9, let-7a,
7b, and miR-22* were found to be up-regulated in trans-
formed IEC-6 cells, whereas miR-539, miR-181d, and
miR-146a were down-regulated. Additionally, the expres-
sions of five miRPlus were also altered in transformed
IEC-6 cells, although their identities have not been fully
confirmed. The results on miRNAs displaying more or less
than twofold in transformed IEC-6 cells compared to its
normal controls were summarized in Table 5.
To validate the data of microarray, we partially assessed
the expression of two miRNAs gene by real-time RT-PCR,
using the same RNA samples that were applied to the
microarrays. We were interested in those miRNAs, which
gave strong hybridization signals, and were up-regulated
in transformed cells. So the expression of miR208 and
miR22* was chosen to be validated. As shown in Fig. 3, we
found strong correlation between microarray profiling
and real-time RT-PCR data. This implied that the data
obtained from microarray analysis were partially reliable
at least.
Table 4: Differentially expressed genes related to cell transformation
GeneBank no Symbol Description Ratio
NM_057138 Cflar CASP8 and FADD-like apoptosis regulator, 2.06
NM_017059 Bax Bcl2-associated X protein, 2.23
XM_235169 Mdm2 Transformed mouse 3T3 cell double minute 2, 2.73
XM_574426 Ccne1 Cyclin E 2.17
NM_001014786 Ifna1 Interferon-alpha 1 7.38
NM_031507 Egfr Epidermal growth factor receptor 2.50
NM_022197 Fos FBJ murine osteosarcoma viral oncogene homolog 6.50
NM_012603 Myc Myelocytomatosis viral oncogene homolog (avian) 3.43
XM_230950 Itgav_predicted Integrin alpha V (predicted) 3.22
NM_031334 Cdh1 Cadherin 1 0.07
NM_013135 Rasa1 RAS p21 protein activator 1 0.37
Comparison of data obtained by real-time PCR and microar-ray an ly is in transformed and normal IEC-6 cellsFigure 2
Comparison of data obtained by real-time PCR and 
microarray analysis in transformed and normal IEC-6 
cells. Using the housekeeping GPADH gene as a reference 
gene, five selected genes were assessed for expression at the 
mRNA level by Real-time PCR. The ratio, representing the 
relative value of the gene expression level, was expressed as 
a logarithm (log2). Corresponding values obtained by micro-
array analysis were presented for comparison.Page 6 of 10
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It has been reported that aberrant acetylation of histone
was involved in transformation and tumorigenesis. As
large mount of genes and miRNAs were differential
expressed in transformed IEC-6 cells, we wondered
whether acetylation status of histone was also changed.
Total proteins of normal and MNNG/PMA treated IEC-6
cells were isolated and detected by western blot with spe-
cific antibody against acetylated histone H3. Result
showed the levels of acetylated histone H3 were low in
normal IEC-6 cells, and it increased dramatically after
MNNG/PMA treatment (Fig. 4). Furthermore, more times
treated with MNNG/PMA, more increase of acetylated his-
tone H3 was observed. This indicated that MNNG/PMA
treatment leaded to increased level of acetylated histone
H3, and thus altered gene expression.
Discussions
Substantial advances in our understanding during the past
decades have led to a complete understanding of the role
of both environmental and genetic factors in colorectal
cancer pathogenesis. It has been well demonstrated that
the its development and progress are associated with
deregulation of many genes, as well as mutational activa-
tion of oncogenes and loss of function of tumor suppres-
sor genes [22]. And its tumorigenesis is also a process of
Table 5: Fold change in microRNAs in IEC-6 cells after 
transformation.
miRNA Localization Normal Transformed Ratio
miRPlus_17843 NDa 103.8 45.7 0.44
miRPlus_17858 NDa 109.5 41.5 0.38
miRPlus_17896 NDa 10457.5 27921.5 2.67
miRPlus_30317 NDa 137.5 782.4 5.69
miRPlus_30908 NDa 8473.3 19149.7 2.26
rno-let-7a Intergenic, 17p14 10423.0 24709.6 2.37
rno-let-7b Intergenic, 7q34 13462.8 42003.9 3.12
rno-miR-208 Intron, 15p13 11755.5 38910.7 3.31
rno-miR-9 Intergenic, 2q34 10761.0 28839.5 2.68
rno-miR-22* Intergenic, 10q24 3401.3 8333.2 2.45
rno-miR-194 Intron, 13q26 1083.5 2405.4 2.22
rno-miR-126 Intron, 3p13 2880.7 6049.5 2.10
rno-miR-185 Intron, 11q23 34540.0 70461.6 2.04
rno-miR-217 Intergenic, 14q22 359.7 748.2 2.08
rno-miR-184 Intron, 8q31 23366.7 48656.7 2.08
rno-miR-146a Intergenic, 10q21 130.5 57.4 0.44
rno-miR-292-5p Intergenic, 1q12 107.5 41.9 0.39
rno-miR-30e Intron, 5q36 115.8 55.6 0.48
rno-miR-539 Intergenic, 6q32 141.8 68.1 0.48
rno-miR-181d Intergenic, 19q11 489.3 225.1 0.46
a: not determined.
Comparison of data obtained by real-time PCR and microar-ray an ly is in transformed and normal IEC-6 cellsFigure 3
Comparison of data obtained by real-time PCR and 
microarray analysis in transformed and normal IEC-6 
cells. Using the U6 gene as a reference gene, 2 selected 
miRNA genes were assessed for expression by Real-time 
PCR. Corresponding values obtained by microarray analysis 
were presented for comparison.
Western blot analisis of acetylated histone H3 in IEC-6 cellsFigure 4
Western blot analisis of acetylated histone H3 in 
IEC-6 cells. Total protein (30 μg per lane) was resolved on 
SDS-polyacrylamide gel and transferred onto a nitrocellulose 
membrane and incubated with anti-acetylated histone H3 and 
anti-GAPDH antibodies. The bands were visualized by using 
the enhanced chemiluminescence system. The relative abun-
dances of acetylated histone H3 was normalized by that of 
GAPDH. Lane1: normal IEC-6 cells; Lane2: IEC-6 cells 
treated with MNNG/PMA for 6 times; Lane2: IEC-6 cells 
treated with MNNG/PMA for 12 times.Page 7 of 10
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genetic pathways are involved in colorectal cancer. The
most troublesome bewilderment is that different profile
of mutant genes leads to the same clinical phenotype. So
the detailed molecular mechanism of colorectal cancer
has not been fully understood.
Many important biological processes were involved in
transformation and tumorigenesis, including cell cycle
control, DNA damage repair, cell apoptosis and signal
transduction. The rat Oligo GEArray microarray profiles
the expression of 113 genes representative of the six bio-
logical pathways involved in transformation and tumori-
genesis. It has been applied in many experiments [23,24].
Our results showed that most of the six biological path-
ways were involved in transformation of IEC-6 cells. This
indicated that transformation were the consequence of
multiple deregulations of genes. Among the genes differ-
entially expressed, some were also found altered in tumor
by other researchers. Our experiment showed that c-fos
was up-regulated greatly in transformed cells. Many exper-
imental and clinical data indicated that c-fos expression
plays a role in the progression of several types of carcino-
mas [25]. Increased expression of c-fos was also found to
be associated with metastasising ability of metastatic
colorectal cancer by cDNA macroarray analysis [26].
Another gene increased greatly in transformed IEC-6 cells
was Ifna1, which played an important role in angiogen-
esis of tumor. Ifna1 plays a pivotal role not only in antivi-
ral immunity but also in the surveillance of cancer
development. It has showed that Ifna1 was endowed with
marked antiangiogenic activity in breast cancer and ovar-
ian cancer models, and considered as a suitable candidate
gene for this therapeutic approach [27,28]. However, the
functional significance of increased Ifna1 in transformed
IEC-6 cells was unclear. Cdh1 was showed to be down reg-
ulated in transformed IEC-6 cells, which was coincident
with others' findings. Cdh1 played a key role in cell-cell
adhesion. Inactivation of the cdh1 mediated cell adhesion
system was a common finding in human cancers, indicat-
ing that cdh1 function as tumor suppressor and invasion
suppressor genes [29,30].
miRCURY microRNA chips contained totally 2056
probes, including human, mouse and rat miRNA genes.
So it has been broadly applied in many research works
[31,32]. Our data indicated several miRNAs were highly
expressed in IEC-6 cells and 20 miRNAs showed evidence
of being differentially expressed within the transformed
IEC-6 cells. Among these differentially expressed miRNAs,
we verified the alteration of miR-208 and miR-22*. miR-
208 is encoded by intron 27 of the human and mouse
MHC gene. Consistent with the specific expression of
MHC in the heart and the pulmonary myocardium, miR-
208 is expressed specifically in the heart and at trace levels
in the lung [33]. The relationship between miR-208 and
tumorigenesis was not clear and needed further study.
miR-22* and miR-22 are the alternative mature type of
their primary precursors. Increased miR-22 was found in
erythropoiesis, and it was predicted to target genes
involved in cell development and differentiation [34].
Our result showed miR-22* was increased, but not miR-
22. This suggested that the maturation of primary precur-
sor was selectively processed. Partial differential expressed
miRNAs in transformed IEC-6 cells were consistent with
the results of others. Gottardo F et al found significant up-
regulation of miR-185 in renal cell carcinoma compared
to normal kidney [35]. Many targets have been reported
for miR-185, including genes of the proto-cadherin gene
cluster. However, we didn't find the directly relationship
between altered miRNAs and the specific genes in our
experiment.
Our results suggested that transformation of IEC-6 cells
did not derived from a single gene, but rather through
accumulated changes in the expression of several different
genes involved in many biological pathways. So it was
necessary to find out the reason why genes were deregu-
lated at chromosomal levels. In the past few decades, evi-
dence has accumulated showing that modifications of
histone acetylation status have a central role in carcino-
genesis [36-38]. Aberrant activation of histone deacety-
lases in tumour cells leads to transcriptional deregulation
of a diverse set of genes mainly involved in the regulation
of proliferation, migration, angiogenesis, and invasion. In
this study, we showed that the increased level of acetyla-
tion of histone H3 was observed in transformed IEC-6
cells. We speculated that treatment of MNNG/PMA could
modify the histone acetylation status, and gave rise to
altered gene expression of transformed cells.
Conclusion
This study showed IEC-6 cells were successfully trans-
formed and the corresponding altered gene expression
was compared by microarray analysis. This strategy pro-
vided an efficient resolution to analyze the molecular
mechanism of transformation and tumorigenesis of colon
cancer. The preliminarily verified genes will of course be
further studied in order to determine its functions in tum-
origenesis of cancers. Our results showed many important
biological pathways and miRNAs were involved in trans-
formation and tumorigenesis of IEC-6 cells. This sug-
gested the transformation of normal cell was involved
with large mount of genetic and epigenetic variation.
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